Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors

Published:2019-03 Issue:2 Volume:9 Page:e196-e202
ISSN:1879-8500
Container-title:Practical Radiation Oncology
language:en
Short-container-title:Practical Radiation Oncology

Author:

Nguyen Ky Nam B.,Hause Destiny J.,Novak Jennifer,Monjazeb Arta M.,Daly Megan E.

Funder

National Cancer Institute

National Institutes of Health

EMD Serono

Genentech

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference20 articles.

1. Stereotactic body radiation therapy for inoperable early stage lung cancer;Timmerman;JAMA,2010

2. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung xancer;Timmerman;J Clin Oncol,2006

3. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study;Fakiris;Int J Radiat Oncol Biol Phys,2009

4. Central-airway necrosis after stereotactic body-radiation therapy;Corradetti;N Engl J Med,2012

5. Efficacy and toxicity analysis of NRG oncology/RTOG 0813 trial of stereotactic body radiation therapy (SBRT) for centrally located non-small cell lung cancer (NSCLC);Bezjak;Int J Radiat Oncol Biol Phys,2016

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic Core Ablative Radiation Therapy (SCART) - principal and practice of a novel strategy to treat bulky tumor;2024-06-26

2. Stereotactic central/core ablative radiation therapy: results of a phase I study of a novel strategy to treat bulky tumor;Frontiers in Oncology;2024-05-24

3. Safety and Efficacy of Moderate-Intensity Stereotactic Body Radiation Therapy for Ultra-Central Lung Tumor;Medicina;2024-03-26

4. Accelerated Hypofractionated Magnetic Resonance Guided Adaptive Radiation Therapy for Ultracentral Lung Tumors;Tomography;2024-01-17

5. Evaluation of a New Method for CyberKnife Treatment for Central Lung and Mediastinal Tumors by Tracheobronchial Tracking;Technology in Cancer Research & Treatment;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3